BioCatalystWatch
CBIOWorkspace / CBIO / OverviewCompany library
CRESCENT BIOPHARMA, INC. logo

CRESCENT BIOPHARMA, INC.

CRESCENT BIOPHARMA, INC. (CBIO)

Website

Price
Market cap
Next catalystExpected Q1 2027CR-003 (SKB105) — China monotherapy study · Phase 1/2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

CR-001

PD-1 × VEGF

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

CR-002

PD-L1

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CR-001

PD-1 × VEGF

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

CR-002

PD-L1

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

Partner / License out

CR-001

PD-1 × VEGF

PreINDP1P2P3FilingApproved
Upcoming / outlook

CR-001

PD-1 × VEGF

CR-001

PD-1 × VEGF

PreINDP1P2P3FilingApproved
CR-001

PD-1 × VEGF

PreINDP1P2P3FilingApproved

History / paused

E-selectin

E-selectin

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CBIO PR & News

PR & News

CBIO SEC archive